ReviewDiabetology & metabolic syndrome2025

The effect of melanocortin-4 receptor agonist drugs on obesity and metabolic risk factors: a systematic review and meta-analysis.

Yanan Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.